DiscoverLaboratory Considerations for Clinical TrialsRisk Management for Biotech Companies in Clinical Trials
Risk Management for Biotech Companies in Clinical Trials

Risk Management for Biotech Companies in Clinical Trials

Update: 2022-05-16
Share

Description

In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.


Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach. 


Alex and Alan talk about:


  • How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur. 

  • What sponsors can do to reduce the risks for their study

  • How Q2 Solutions' in-house scientific and regulatory expertise ensure that your data are compliant to global regulations


You can learn more at https://q2labsolutions.com/biotech.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Risk Management for Biotech Companies in Clinical Trials

Risk Management for Biotech Companies in Clinical Trials

Q Squared Solutions